Adrenal cortex supplements are commonly marketed for fatigue, stress, and nonspecific somatic complaints, often promoted for “adrenal fatigue.” The condition is not recognized in formal medical ...

Specific phobia is among the most prevalent anxiety disorders in epidemiological surveys. 1 The DSM-5 classifies specific phobias into 5 subtypes: animal, natural environment, blo ...

Objective: Lumateperone is an FDA-approved atypical antipsychotic to treat schizophrenia, bipolar I or II depression, and major depressive disorder (MDD). Post hoc analyses of a randomized, phase 3, ...

The strongest associations were observed for sister's postpartum psychosis, cyclothymia, schizoaffective disorder, and ...

The Journal of Clinical Psychiatry | 2021, Volume 82 ...

For most patients, depression reflects the combined influence of biological vulnerability, symptom burden, functional ...

Conceptual issues, methodological issues, and findings related to long-term risk of dementia with ECT are discussed.

Findings from an analysis of 10 studies suggest lithium is effective in preventing postpartum recurrence of mood disorders.

Negative symptoms of schizophrenia improved more with a digital therapeutic than with a control app, but durability and ...

Early clinical improvement, not baseline traits, was associated with response to adjunctive lumateperone in MDD, though its ...

In this webinar, Balwinder Singh, MD, and Raman Baweja, MD, describe emerging evidence on GLP-1 receptor agonists for long-term kidney protection in bipolar disorder with chronic kidney disease. They ...

Objective: To evaluate the benefit of pharmacotherapies for adults with co-occurring stimulant use disorder (StUD) and attention-deficit/hyperactivity disorder (ADHD ...